IDH-WILDTYPE GLIOBLASTOMA
Clinical trials for IDH-WILDTYPE GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new IDH-WILDTYPE GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for IDH-WILDTYPE GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for aggressive brain cancer? early trial of ERAS-801 begins
Disease control Recruiting nowThis early-phase trial tests the safety of a drug called ERAS-801 in 10 adults with recurrent glioblastoma, a fast-growing brain cancer. The drug targets a protein called EGFR that is overactive in many of these tumors. Researchers will also check if the drug affects tumor activi…
Matched conditions: IDH-WILDTYPE GLIOBLASTOMA
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could the time you take chemo make a difference? new trial investigates
Symptom relief Recruiting nowThis pilot study looks at whether taking the chemotherapy drug temozolomide at a specific time of day (morning or evening) is practical for people with glioblastoma, a type of brain cancer. Fifty adults who have completed surgery and radiation will be randomly assigned to take th…
Matched conditions: IDH-WILDTYPE GLIOBLASTOMA
Phase: NA • Sponsor: Ottawa Hospital Research Institute • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC